Localizing a brain network of progressive supranuclear palsy
Objective: To localise brain networks of progressive supranuclear palsy (PSP), using a novel method termed ‘Coordinate Network Mapping’. Background: PSP has multiple phenotypes including, but…PSP registry: preliminary cross-sectional results of the first 2 years of recruitment of a multicenter registry and biorepository.
Objective: To establish a multicenter PSP registry and biorepository in a province covering an area of 5,500,000 inhabitants, with 14 local and university hospitals. Background:…Atypical Parkinsonian Syndrome with evocative brain MRI imaging. About seven cases.
Objective: The diagnosis of Parkinson's disease and parkinsonian syndromes remains clinically difficult, is based on clinical diagnostic criteria, MRI plays a major role in the…Neuroimaging analysis of postural instability in Progressive Supranuclear Palsy: a Voxel‐based morphometry approach
Objective: The aim of the study was to identify the mainly brain regions involved in postural instability (PI) in Progressive Supranuclear Palsy (PSP) with a…White matter integrity in patients with PSP-RS and VaP: A TBSS Study
Objective: The purpose of the present study was to compare alterations of brain white-matter microstructure and tissue integrity in PSP-RS and VaP patients using Diffusion…A tau-directed monoclonal antibody could alter the tau pathology of progressive supranuclear palsy
Objective: The purpose of this study is to examine the modification of tau pathology in brain regions of a patient with progressive supranuclear palsy (PSP)…Introducing the molecular subtyping of Progressive Supranuclear Palsy: a proof of concept
Objective: To enhance understanding of the molecular mechanisms underlying disease heterogeneity in Progressive supranuclear palsy (PSP) Background: PSP is a 4R-tauopathy characterised by subcortical pathology…In vivo proteomic investigation of deeply phenotyped parkinsonian syndromes for biomarkers of differential diagnosis
Objective: To investigate deeply-phenotyped cohorts of parkinsonian syndromes using proteomic technologies for identification of biomarkers for differential diagnosis Background: Proteomic technologies like Olink® Explore 3072…Prognostic impact of frontal-lobe clinical bedside signs in progressive supranuclear palsy
Objective: To identify clinical bedside examination signs indicative of frontal lobe dysfunction with a prognostic value in patients with progressive supranuclear palsy (PSP). Background: The…Atypical progression of motor symptoms in Facio-Scapulo-Humeral Dystrophy: clinical worsening or overlap?
Objective: This case highlights the importance of considering possible overlaps with PSP and other neurodegenerative diseases. Background: Facio-Scapulo-Humeral Dystrophy is a common muscular dystrophy featuring…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 38
- Next Page »